While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

The Food and Drug Administration is planning to expand its review of food additives beyond artificial dyes, targeting ...

The U.S. Food and Drug Administration plans to step up safety reviews on chemicals in foods, including one widely used as a ...

The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.

Atzumi, a dihydroergotamine (DHE) nasal powder, was approved by the Food and Drug Administration (FDA) for the acute ...

Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.